MetLife Investment Advisors »

Stoke Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $77k 15k 5.26
2023-09-30 $58k 15k 3.94
2023-06-30 $155k 15k 10.63
2023-03-31 $97k 12k 8.33
2022-12-31 $107k 12k 9.23
2022-09-30 $149k 12k 12.84
2022-06-30 $154k 12k 13.25
2022-03-31 $245k 12k 21.08
2021-12-31 $176k 7.3k 23.99
2021-09-30 $187k 7.3k 25.44
2021-06-30 $247k 7.3k 33.69
2021-03-31 $213k 5.5k 38.84
2020-12-31 $339k 5.5k 61.90
2020-09-30 $262k 7.8k 33.49
2020-06-30 $186k 7.8k 23.81
2020-03-31 $179k 7.8k 22.91
2019-12-31 $135k 4.8k 28.35